Skip to main content
Equibles

Michael King

CFO

SAB Biotherapeutics, Inc. (SABS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael King

Michael King is recorded as CFO at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed October 27, 2023 that Michael King was appointed Chief Financial Officer, effective October 30, 2023.

“On October 23, 2023, Michael King, age 62, was appointed Chief Financial Officer of SAB Biotherapeutics, Inc., a Delaware corporation (the "Company"), effective October 30, 2023.”
SAB Biotherapeutics, Inc. Form 8-K, filed October 27, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at SAB Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.